Other Recent Developments In July, Inspire Medical announced preliminary, unaudited results for second-quarter 2024 and updated its full-year 2024 revenue outlook. The company anticipates second ...

Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81.

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

“We are also excited to announce the first implants of the new Inspire V neurostimulation system, and a new organizational ... for patients with obstructive sleep apnea. Inspire’s proprietary ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment ... such as ResMed (RMD) and Inspire Medical Systems (INSP). - Inspire has developed a neurostimulation device ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Inspire Medical Systems, Inc. announced preliminary fourth ... invasive solutions for patients suffering from obstructive sleep apnea. Disclaimer: This is an AI-generated summary of a press ...

Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81. Jim Cramer Predicts Palantir Buying Surge Tonight After Morgan ...

MINNEAPOLIS, Minn, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE ... invasive solutions for patients with obstructive sleep apnea, today announced certain preliminary ...